
Association of Progressive Supranuclear Palsy Rating Scale with Progressive Supranuclear Palsy Quality of Life Scale
Author(s) -
Alexander Pantelyat,
Lenora Higginbotham,
Liana S. Rosenthal,
Diane C. Lanham,
Vanessa Nesspor,
Mina AlSalihi,
Jee Bang,
Jiangxia Wang,
Marilyn Albert
Publication year - 2020
Publication title -
neurodegenerative diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.98
H-Index - 57
eISSN - 1660-2862
pISSN - 1660-2854
DOI - 10.1159/000514519
Subject(s) - progressive supranuclear palsy , rating scale , medicine , quality of life (healthcare) , physical medicine and rehabilitation , psychology , disease , developmental psychology , nursing
There is growing interest in using patient-reported outcomes as end points in clinical trials, such as the progressive supranuclear palsy quality of life (PSP-QoL) scale. However, this tool has not been widely validated and its correlation with validated motor scales has not been explored. To evaluate the potential utility of using PSP-QoL as an outcome, it is important to examine its relationship with a standard scale used to evaluate neurologic parameters, such as the PSP Rating Scale.